Loading cancer entity…
Loading cancer entity…
Clinical trials
6,746 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,045)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00890903 | Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC) | completed | — | 62 | Pierre Fabre Pharma GmbHINDUSTRY | 1 | Jul 2, 2012 | clinicaltrials |
| NCT01023828 | K-RAS Oncogene Mutation in Patients With Advanced Non-Small Cell Lung Cancer Associated With Exposure to Wood Smoke and Tobacco Smoking: Therapeutic Implications(007/055/OMI) | completed | — | 150 | National Institute of CancerologíaOTHER_GOV |
| 1 |
| Jun 29, 2012 |
| clinicaltrials |
| NCT01314677 | Fludeoxyglucose F 18 PET/CT Scans in Predicting Therapy Response in Patients With Stage IIIA Non-Small Cell Lung Cancer Undergoing Chemoradiation | withdrawn | N/A | 0 | City of Hope Medical CenterOTHER | 0 | Jun 29, 2012 | clinicaltrials |
| NCT00522938 | Clinical Trial of the Safety and Effectiveness of CHR-2797 With Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer | terminated | Phase 1 / Phase 2 | 2 | Chroma TherapeuticsINDUSTRY | 1 | Jun 28, 2012 | clinicaltrials |
| NCT00826878 | An Open-Label Study of QD Oral Administration of Tivozanib (AV-951) in Subjects With Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 1 | 17 | AVEO Pharmaceuticals, Inc.INDUSTRY | 1 | Jun 28, 2012 | clinicaltrials |
| NCT01574729 | Surgery Combined With rAd-p53 Gene in Treatment Advanced Non-small-cell Carcinoma(rAd-p53) | unknown | Phase 2 | 120 | Shenzhen SiBiono GeneTech Co.,LtdINDUSTRY | 1 | Jun 28, 2012 | clinicaltrials |
| NCT00442026 | Randomized Trial of Docetaxel and Gemcitabine Versus Gemcitabine in Elderly Patients With NSCLC | terminated | Phase 3 | 106 | Hellenic Oncology Research GroupOTHER | 1 | Jun 27, 2012 | clinicaltrials |
| NCT00094094 | Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 32 | PfizerINDUSTRY | 2 | Jun 26, 2012 | clinicaltrials |
| NCT01502202 | Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never Smokers | unknown | Phase 2 | 162 | National Cancer Center, KoreaOTHER_GOV | 1 | Jun 20, 2012 | clinicaltrials |
| NCT00887549 | A Study of Thymidylate Synthase Expression in Patients With Non-Small Cell Lung Cancer | completed | Phase 2 | 70 | Eli Lilly and CompanyINDUSTRY | 2 | Jun 19, 2012 | clinicaltrials |
| NCT01619241 | Pilot Study for Evaluating the Role of F-18 FLT PET/CT in Therapeutic Decision Making in Non-small Cell Lung Cancer | unknown | — | 15 | The Catholic University of KoreaOTHER | 1 | Jun 14, 2012 | clinicaltrials |
| NCT00367679 | Pazopanib As Pre-Surgical Therapy In Treatment-Naive Subjects With Non-Small Cell Lung Cancer | completed | Phase 2 | 35 | GlaxoSmithKlineINDUSTRY | 3 | Jun 12, 2012 | clinicaltrials |
| NCT00312975 | Randomized Study Of CP-675,206 or Best Supportive Care Immediately After Platinum-Based Therapy For Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 90 | AstraZenecaINDUSTRY | 5 | Jun 7, 2012 | clinicaltrials |
| NCT00478049 | Iressa as Second Line Therapy in Advanced NSCLC-Asia(ISTANA) | completed | Phase 3 | 163 | AstraZenecaINDUSTRY | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00745875 | ZD4054 (Zibotentan) Phase II Non-Small Cell Lung Cancer Study | completed | Phase 2 | 66 | AstraZenecaINDUSTRY | 5 | Jun 6, 2012 | clinicaltrials |
| NCT00088556 | Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 100 | TelikINDUSTRY | 1 | May 31, 2012 | clinicaltrials |
| NCT00042315 | A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of Tariquidar + Vinorelbine as First-Line Therapy in Non-Small Cell Lung Cancer (NSCLC) | terminated | Phase 3 | 490 | QLT Inc.INDUSTRY | 0 | May 23, 2012 | clinicaltrials |
| NCT00330746 | CALC-1 (Cetuximab in Advanced Lung Cancer): Study of 2 Methods of Combining Cetuximab and Gemcitabine in Patients With Advanced Non Small-cell Lung Cancer(CALC-1) | completed | Phase 2 | 100 | National Cancer Institute, NaplesOTHER | 1 | May 18, 2012 | clinicaltrials |
| NCT01493011 | Chemotherapy Combined With Whole-body Hyperthermia to Treat Stage IIIB/IV Non Small Cell Lung Cancer(WBH&NSCLC) | unknown | N/A | 120 | Xijing HospitalOTHER | 1 | May 15, 2012 | clinicaltrials |
| NCT00251446 | A Phase II Single Arm Trial of Single-agent Vinflunine as Second-line Treatment of Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 70 | Veeda OncologyOTHER | 1 | May 11, 2012 | clinicaltrials |
| NCT00251524 | A Phase II Study of Eloxatin and Alimta in Combination With Bevacizumab in Advanced Non-Squamous NSCLC | completed | Phase 2 | 69 | Veeda OncologyOTHER | 1 | May 11, 2012 | clinicaltrials |
| NCT01593293 | Pemetrexed With or Without Carboplatin for Elderly Non-squamous Non-small Cell Lung Cancer(ACE) | unknown | Phase 3 | 266 | Asan Medical CenterOTHER | 1 | May 8, 2012 | clinicaltrials |
| NCT00098254 | BAY 43-9006 (Sorafenib) to Treat Relapsed Non-Small Cell Lung Cancer | completed | Phase 2 | 37 | National Cancer Institute (NCI)NIH | 1 | May 2, 2012 | clinicaltrials |
| NCT00291850 | Phase II Trial of Dose-dense Paclitaxel and Cisplatin as Neo-adjuvant Chemotherapy for Operable Stage II and IIA NSCLC | terminated | Phase 2 | 50 | Central European Cooperative Oncology GroupOTHER | 3 | May 1, 2012 | clinicaltrials |
| NCT00268970 | Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 40 | AgennixINDUSTRY | 1 | Apr 30, 2012 | clinicaltrials |
| NCT00807066 | Randomized Gefitinib Trial(RANGE) | completed | Phase 3 | 1 | Fondazione Humanitas per la RicercaOTHER | 1 | Apr 23, 2012 | clinicaltrials |
| NCT01581346 | Exercise Study in Patients With Lung Cancer(POSITIVE) | completed | Phase 2 | 40 | German Cancer Research CenterOTHER | 1 | Apr 20, 2012 | clinicaltrials |
| NCT00652340 | APRiCOT-L: Study to Evaluate Efficacy and Safety of Apricoxib With Erlotinib in Patients With Non-small Cell Lung Cancer(TP2001-201) | completed | Phase 2 | 120 | Tragara Pharmaceuticals, Inc.INDUSTRY | 1 | Apr 9, 2012 | clinicaltrials |
| NCT00692640 | Safety Study of XL147 (SAR245408) in Combination With Erlotinib in Adults With Solid Tumors | completed | Phase 1 | 35 | SanofiINDUSTRY | 1 | Mar 23, 2012 | clinicaltrials |
| NCT00442754 | Dendritic Cells in Lung Cancer | completed | Phase 2 | 50 | Herlev HospitalOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT01052766 | Breathing Synchronized PET/CT Scans for the Detection of Malignant Lung & Liver Lesions and Assessment of Tumor Glycolysis | terminated | N/A | 11 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Mar 16, 2012 | clinicaltrials |
| NCT00706862 | Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer(FORTIS-C) | unknown | Phase 3 | 1,100 | AgennixINDUSTRY | 1 | Mar 15, 2012 | clinicaltrials |
| NCT00517595 | Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC | completed | Phase 2 | 48 | Accelerated Community Oncology Research NetworkOTHER | 1 | Mar 12, 2012 | clinicaltrials |
| NCT00816868 | A Phase II Study of TX Regimen as First-line Treatment for Asian Elderly Patients With Advanced Adenocarcinoma of Lung | completed | Phase 2 | 62 | Sun Yat-sen UniversityOTHER | 1 | Mar 1, 2012 | clinicaltrials |
| NCT00637910 | Tarceva Italian Lung Optimization tRial(TAILOR) | unknown | Phase 3 | 850 | Fatebenefratelli and Ophthalmic HospitalOTHER | 1 | Feb 24, 2012 | clinicaltrials |
| NCT00432562 | A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer. | completed | Phase 1 | 31 | Mast Therapeutics, Inc.INDUSTRY | 1 | Feb 23, 2012 | clinicaltrials |
| NCT00034957 | Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC) | completed | Phase 2 | — | PfizerINDUSTRY | 1 | Feb 16, 2012 | clinicaltrials |
| NCT01063400 | Feasibility Study: Comparison of Performance Status With Objective Physical Activity Monitors | terminated | — | 6 | University of Wisconsin, MadisonOTHER | 1 | Feb 14, 2012 | clinicaltrials |
| NCT01270386 | A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer | completed | Phase 2 | 136 | Jiangsu HengRui Medicine Co., Ltd.INDUSTRY | 1 | Feb 10, 2012 | clinicaltrials |
| NCT01527864 | Paclitaxel-Carboplatin Alone or With M2ES for Non-Small-Cell Lung Cancer | unknown | Phase 2 | 300 | Beijing Protgen Biotechnology Development Co., Ltd.INDUSTRY | 1 | Feb 7, 2012 | clinicaltrials |
| NCT00138658 | A Study of OGX-011/Gemcitabine/Platinum-Based Regimen in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 1 / Phase 2 | 85 | Achieve Life SciencesINDUSTRY | 2 | Feb 6, 2012 | clinicaltrials |
| NCT00777699 | Safety Study of XL765 (SAR245409) in Combination With Erlotinib in Adults With Solid Tumors | completed | Phase 1 | 80 | SanofiINDUSTRY | 1 | Feb 3, 2012 | clinicaltrials |
| NCT00408226 | Safety Study of MKC-1 Combined With Pemetrexed to Treat Advanced Cancer and Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 27 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Jan 20, 2012 | clinicaltrials |
| NCT01260038 | Study in NSCLC: is Timely Analysis of EGFR-mutation Status Feasible in Region Antwerp, Belgium.(HERMES) | completed | — | 107 | University Hospital, AntwerpOTHER | 1 | Jan 18, 2012 | clinicaltrials |
| NCT01083589 | Imatinib Mesylate and Docetaxel in Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 22 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 11, 2012 | clinicaltrials |
| NCT01450553 | Tissue Collection Study for Patients With Non-Small Cell Lung Cancer With Resectable Disease | unknown | — | 450 | Precision TherapeuticsINDUSTRY | 1 | Jan 11, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Jul 2, 2012source: clinicaltrials